PCRX is having a pocket pivot in today's trade after a strong earnings report where it came in at -27c vs -43c consensus. Note, this stock carries higher risk because it is a small cap and has no earnings, and in this environment, you want to be involved in better capitalized stocks. However, biotechs can be exempted in certain cases.
Thus, we are reporting on this stock because it is an interesting bio-tech that institutions have been accumulated as institutional sponsorship has climbed every quarter over the last 6 quarters.
Its non-opiate and thus less addictive drug Exparel reduces or eliminates need for opiates to control post-surgical pain. Opiates such as Vicodin or Percacet can be addictive, and a non-opiate alternative for pain management in Exparel may give the company some traction in this space. The question will be how well they can market Exparel since opiates such as Vicodin are household words, and many huge opiate manufacturers out there will seek to compete with Exparel. PCRX might be a slow grower that keeps on growing as public awareness grows.
This information is provided by MoKa Investors, LLC DBA Virtue of Selfish Investing (VoSI) is issued solely for informational purposes and does not constitute an offer to sell or a solicitation of an offer to buy securities. Information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of available data. VoSI reports are intended to alert VoSI members to technical developments in certain securities that may or may not be actionable, only, and are not intended as recommendations. Past performance is not a guarantee, nor is it necessarily indicative, of future results. Opinions expressed herein are statements of our judgment as of the publication date and are subject to change without notice. Entities including but not limited to VoSI, its members, officers, directors, employees, customers, agents, and affiliates may have a position, long or short, in the securities referred to herein, and/or other related securities, and may increase or decrease such position or take a contra position. Additional information is available upon written request. This publication is for clients of Virtue of Selfish Investing. Reproduction without written permission is strictly prohibited and will be prosecuted to the full extent of the law. ©2021 MoKa Investors, LLC DBA Virtue of Selfish Investing. All rights reserved.